These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12704618)

  • 21. Exact two-sample inference with missing data.
    Cheung YK
    Biometrics; 2005 Jun; 61(2):524-31. PubMed ID: 16011700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Test equality and sample size calculation based on risk difference in a randomized clinical trial with noncompliance and missing outcomes.
    Lui KJ; Chang KC
    Biom J; 2008 Apr; 50(2):224-36. PubMed ID: 18264992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving the efficiency of estimation in randomized trials of adaptive treatment strategies.
    Lavori PW; Dawson R
    Clin Trials; 2007; 4(4):297-308. PubMed ID: 17848491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A conditional nonparametric test for comparing two areas under the ROC curves from a paired design.
    Bandos AI; Rockette HE; Gur D
    Acad Radiol; 2005 Mar; 12(3):291-7. PubMed ID: 15766688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment comparisons for a partially categorical outcome applied to a biomarker with assay limit.
    Chen YH; Gould AL; Nessly ML
    Stat Med; 2005 Jan; 24(2):211-28. PubMed ID: 15558832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A permutation test for comparing ROC curves in multireader studies a multi-reader ROC, permutation test.
    Bandos AI; Rockette HE; Gur D
    Acad Radiol; 2006 Apr; 13(4):414-20. PubMed ID: 16554220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of antiretroviral immunotherapy trials with potentially non-normal and incomplete longitudinal data.
    Mogg R; Mehrotra DV
    Stat Med; 2007 Feb; 26(3):484-97. PubMed ID: 16625520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous group sequential analysis of rank-based and weighted Kaplan-Meier tests for paired censored survival data.
    Andrei AC; Murray S
    Biometrics; 2005 Sep; 61(3):715-20. PubMed ID: 16135022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of varying the event generation process in simulation studies of statistical methods for recurrent events.
    Metcalfe C; Thompson SG
    Stat Med; 2006 Jan; 25(1):165-79. PubMed ID: 16217859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonparametric confidence intervals for Tmax in sequence-stratified crossover studies.
    Willavize SA; Morgenthien EA
    Pharm Stat; 2008; 7(1):9-19. PubMed ID: 17256803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Confidence intervals for a difference between proportions based on paired data.
    Tang ML; Ling MH; Ling L; Tian G
    Stat Med; 2010 Jan; 29(1):86-96. PubMed ID: 19823977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power?
    Hernández AV; Eijkemans MJ; Steyerberg EW
    Ann Epidemiol; 2006 Jan; 16(1):41-8. PubMed ID: 16275011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-parametric assessment of non-inferiority with censored data.
    Freitag G; Lange S; Munk A
    Stat Med; 2006 Apr; 25(7):1201-17. PubMed ID: 16345041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of permutation and mixed-model regression methods for the analysis of simulated data in the context of a group-randomized trial.
    Murray DM; Hannan PJ; Pals SP; McCowen RG; Baker WL; Blitstein JL
    Stat Med; 2006 Feb; 25(3):375-88. PubMed ID: 16143991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Power and sample size calculations for discrete bounded outcome scores.
    Tsonaka R; Rizopoulos D; Lesaffre E
    Stat Med; 2006 Dec; 25(24):4241-52. PubMed ID: 16947202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials.
    O'Malley AJ; Normand SL
    Biometrics; 2005 Jun; 61(2):325-34. PubMed ID: 16011678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Letter regarding article by Law et al, "headaches and the treatment of blood pressure: results from a meta-analysis of 94 randomized placebo-controlled trials with 24,000 participants".
    Gupta VK
    Circulation; 2006 Feb; 113(7):e164-5. PubMed ID: 16493784
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter regarding article by Law et al, "headaches and the treatment of blood pressure: results from a meta-analysis of 94 randomized placebo-controlled trials with 24,000 participants".
    Drager LF; Lotufo PA; Bensenor IM
    Circulation; 2006 Feb; 113(7):e164. PubMed ID: 16490829
    [No Abstract]   [Full Text] [Related]  

  • 40. Sense and sensitivity when correcting for observed exposures in randomized clinical trials.
    Vansteelandt S; Goetghebeur E
    Stat Med; 2005 Jan; 24(2):191-210. PubMed ID: 15515152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.